What ESPE does

ESPE (European Society for Paediatric Endocrinology) is a UK-registered charitable medical society founded in 1964 that operates as the primary European professional membership body for paediatric endocrinologists. The organisation is headquartered in London (Company No: 5766541, Charity No: 1122484), structured as a company limited by guarantee, and is governed by a Council of senior clinicians (President: Mehul Dattani). ESPE's core mission is to advance research, education, clinical guidance, and professional community for the subspecialty, addressing the fact that children and adolescents — roughly 20% of the EU population — remain under-served by research funding.

ESPE's product portfolio centres on a multi-channel educational and convening platform. The ESPE-ISPAD E-Learning Platform (espe-elearning.org) is a free, globally accessible interactive learning environment with over 80 chapters and 120 problem-solving clinical cases available in English, French, Spanish, Swahili, Chinese, and Russian, with 30 credit hours of EACCME-accredited CME. This sits alongside the flagship Annual ESPE Meeting (64th edition, Marseille, 8-10 September 2026), the ESPE Connect Webinar Series (free-to-attend, on-demand replays for members), and a portfolio of regional schools: Summer School, Winter School (since 1995), Maghreb School (since 2011, French-speaking North Africa), Caucasus and Central Asia School (since 2014), Diabetes/Obesity/Metabolism School, and the newer ESPE Leadership Academy. Research outputs include the peer-reviewed journal Hormone Research in Paediatrics (Impact Factor 3.8, 2026), consensus statements, yearbooks, and patient booklets. Clinical infrastructure includes the Clinical Fellowship Programme and the YES (Young ESPE) Group pipeline for early-career professionals.

ESPE's commercial model is that of a non-profit professional society, monetised through three primary streams: (1) annual membership subscriptions (January-to-December cycle, no pro-rata), (2) registration and sponsorship revenue from the Annual Meeting and regional schools, and (3) corporate sponsorship and educational grants from pharmaceutical companies including Kyowa Kirin Ltd, with historical support from Ferring Pharmaceuticals and the EU Seventh Framework Programme. Customers are individual paediatric endocrinologists, fellows and trainees (primary), plus healthcare professionals in resource-limited settings (Maghreb, Caucasus & Central Asia, Sub-Saharan Africa via PETCA/PETCWA). Strategic partnerships include the European Society for Endocrinology (joint Endo-ERN Reference Network, 100+ centres in 28 countries), ISPAD (joint e-learning platform and African training), and BSPED/ASPAE for African training programmes.

Name

ESPE

Legal name

European Society for Paediatric Endocrinology

Website

https://eurospe.org

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

1–10 employees

Short description

ESPE is a UK-registered charitable medical society, founded in 1964, that serves as the leading European professional membership body for paediatric endocrinologists, delivering accredited e-learning, regional schools, an annual scientific meeting, and the peer-reviewed journal Hormone Research in Paediatrics.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Membership Fees: Annual membership fees provide access to member benefits including journals, newsletters, discounted event registration, and access to the members section of the ESPE website
2. Annual Meeting Registration: Revenue generated from registration fees for the Annual ESPE Meeting and other educational events
3. Corporate Sponsorship: Sponsorship from pharmaceutical companies such as Kyowa Kirin Ltd and other educational grants for programs and events

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

ESPE is a non-profit professional society that advances paediatric endocrinology through education, training, and research programs. It serves paediatric endocrinologists, clinical researchers, and trainees by providing an annual scientific meeting, e-learning courses, focused clinical schools (Winter and Summer), clinical and research fellowships, the peer-reviewed journal Hormone Research in Paediatrics, and clinical practice guidelines.

Product overview

ESPE (European Society for Paediatric Endocrinology) offers a comprehensive portfolio of educational products and services for the paediatric endocrinology community. The core offering includes the ESPE e-Learning Platform (espe-elearning.org), a free interactive learning environment with over 80 chapters and 120 clinical cases, and the ESPE Connect Webinar Series providing ongoing educational content. ESPE organizes the Annual Meeting (64th in 2026 in Marseille) as its flagship conference. The portfolio includes multiple regional schools (Summer School, Winter School, Maghreb School, Caucasus & Central Asia School, Diabetes/Obesity/Metabolism School) and the new Leadership Academy. Additional services include the Clinical Fellowship Programme, YES Group for early career members, grants and awards, the Hormone Research in Paediatrics journal (impact factor 3.8), and participation in the European Reference Network on Rare Endocrine Conditions (Endo-ERN).

Differentiator

Problem solved

Functional benefit

Products and services

• ESPE Annual Meeting
• ESPE E-Learning Platform
• ESPE Winter School
• ESPE Summer School
• ESPE Clinical and Research Fellowships
• Hormone Research in Paediatrics
• ESPE Individual Membership

Quantifiable outcome

• Hormone Research in Paediatrics achieved Impact Factor of 3.8

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• European Society for Endocrinology (ESE)coreStrategic or Co-development PartnerESPE collaborates with ESE to establish the European Reference Network for Rare Endocrine Disorders (Endo-ERN), a network of 100+ Reference Centres in 28 countries that offers access to clinical experts for patient rare endocrine conditions, secure virtual consultations, rare disease registries (EuRRECa), and patient information endorsed by European Patient Advocacy Groups.
• International Society for Paediatric and Adolescent Diabetes (ISPAD)coreStrategic or Co-development PartnerESPE and ISPAD jointly support the Paediatric Endocrine Training Centers for Africa (PETCA) and Paediatric Endocrine Training Centers for West Africa (PETCWA) programmes in sub-Saharan Africa. They also co-developed the ESPE-ISPAD e-learning platform with over 80 chapters and 120 clinical cases.
• British Society for Paediatric Endocrinology and Diabetes (BSPED)minorStrategic or Co-development PartnerBSPED partners with ESPE and ISPAD to support PETCA training programs in sub-Saharan Africa for specialty training in endocrinology and diabetes.
• African Society for Paediatric and Adolescent Endocrinology (ASPAE)minorStrategic or Co-development PartnerPETCA graduates catalyzed the establishment of ASPAE, which works to advance paediatric endocrinology across Africa.
• Kyowa Kirin LtdminorOthersKyowa Kirin Ltd from Japan is acknowledged as the current sponsor of the ESPE e-learning website.
• Ferring PharmaceuticalsminorOthersFerring generously sponsored the inaugural ESPE Caucasus & Central Asia School in 2014.
• Endo-ERN / EuRRECacoreTechnology or IntegrationCollaboration with Endo-ERN and EuRRECa (European Registries for Rare Endocrine Conditions) for the Gender Incongruence module core registry, facilitating data collection, outcome tracking, and international multicenter collaboration.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Regional players

• British Society for Paediatric Endocrinology and Diabetes (BSPED): UK national paediatric endocrinology society and ESPE partner. BSPED serves a narrower UK membership but co-delivers PETCA training programmes and overlaps in clinical guideline development, making it a smaller regional analogue of ESPE's operating model.
• Sociedad Latinoamericana de Endocrinología Pediátrica (SLEP): Latin American paediatric endocrinology society running regional congresses and training schools. SLEP's Spanish-language programmes parallel ESPE's Maghreb/Spanish outreach, with shared mission but different geographic catchment.
• African Society for Paediatric and Adolescent Endocrinology (ASPAE): Africa-wide paediatric endocrinology society catalysed by PETCA graduates and supported by ESPE. ASPAE represents the next layer of regional organisation beyond ESPE's training programmes, with overlapping subspecialty focus and shared membership pathways.
• Asia Pacific Paediatric Endocrine Society (APPES): Regional paediatric endocrinology society covering Asia-Pacific. APPES runs biennial scientific meetings and similar CME/training programmes for paediatric endocrinologists, comparable in mission but geographically non-overlapping with ESPE.

Broad incumbents

• Endocrine Society: Large US-headquartered endocrinology society with broader (adult and paediatric) scope. Comparable governance and CME-led model but operates at substantially larger scale; overlaps with ESPE for guideline authority and continuing medical education in endocrinology.
• European Academy of Paediatrics (EAP): Umbrella paediatric society covering all paediatric subspecialties in Europe. EAP competes with ESPE for general paediatric CME hours and policy voice at the EU level while operating a broader, less subspecialised mandate.

Direct peers

• European Society for Paediatric Research (ESPR): European society promoting paediatric research across subspecialties. ESPR is adjacent in mission (research and education in paediatrics) and overlaps with ESPE for journal authorship, conference attendance, and policy advocacy at the EU level.
• Pediatric Endocrine Society (PES): US-based counterpart society for paediatric endocrinology. PES is the North American equivalent, running its own annual meeting, fellowships, and journals (e.g., Hormone Research in Paediatrics' transatlantic competitor publications), with overlapping clinical guidelines and member profiles.
• European Society of Endocrinology (ESE): Direct peer and core strategic partner. ESE co-leads the European Reference Network for Rare Endocrine Disorders (Endo-ERN, 100+ Reference Centres, 28 countries) with ESPE and hosts joint congresses, serving an overlapping but broader (adult-inclusive) endocrinology membership across Europe.
• International Society for Paediatric and Adolescent Diabetes (ISPAD): Closest direct peer: ISPAD is a sister society focused on paediatric and adolescent diabetes, co-develops the ESPE-ISPAD e-learning platform, and jointly runs PETCA/PETCWA training programmes in sub-Saharan Africa. Member overlap and programme co-delivery make it the most comparable society to ESPE.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/european-society-for-paediatric-endocrinology

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ESPE